Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1152

1.

(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.

Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X.

J Nucl Med. 2007 Jul;48(7):1162-71. Epub 2007 Jun 15.

PMID:
17574975
[PubMed - indexed for MEDLINE]
Free Article
2.

microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

Wu Y, Zhang X, Xiong Z, Cheng Z, Fisher DR, Liu S, Gambhir SS, Chen X.

J Nucl Med. 2005 Oct;46(10):1707-18.

PMID:
16204722
[PubMed - indexed for MEDLINE]
Free Article
3.

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.

J Nucl Med. 2004 Oct;45(10):1776-83.

PMID:
15471848
[PubMed - indexed for MEDLINE]
Free Article
4.

Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.

Cai W, Chen K, Li ZB, Gambhir SS, Chen X.

J Nucl Med. 2007 Nov;48(11):1862-70. Epub 2007 Oct 17.

PMID:
17942800
[PubMed - indexed for MEDLINE]
Free Article
5.

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.

Li ZB, Chen K, Chen X.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1100-8. doi: 10.1007/s00259-007-0692-y. Epub 2008 Jan 19.

PMID:
18204838
[PubMed - indexed for MEDLINE]
6.

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC.

Cancer Res. 2002 Nov 1;62(21):6146-51.

PMID:
12414640
[PubMed - indexed for MEDLINE]
Free Article
7.

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.

Liu Z, Li ZB, Cao Q, Liu S, Wang F, Chen X.

J Nucl Med. 2009 Jul;50(7):1168-77. doi: 10.2967/jnumed.108.061739. Epub 2009 Jun 12.

PMID:
19525469
[PubMed - indexed for MEDLINE]
Free Article
8.

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.

Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X.

J Nucl Med. 2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16.

PMID:
18632815
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.

Dijkgraaf I, Liu S, Kruijtzer JA, Soede AC, Oyen WJ, Liskamp RM, Corstens FH, Boerman OC.

Nucl Med Biol. 2007 Jan;34(1):29-35.

PMID:
17210459
[PubMed - indexed for MEDLINE]
10.

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ.

Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.

PMID:
19489579
[PubMed - indexed for MEDLINE]
11.

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.

Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS.

Mol Imaging Biol. 2004 Sep-Oct;6(5):350-9.

PMID:
15380745
[PubMed - indexed for MEDLINE]
12.

alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.

Yoshimoto M, Ogawa K, Washiyama K, Shikano N, Mori H, Amano R, Kawai K.

Int J Cancer. 2008 Aug 1;123(3):709-15. doi: 10.1002/ijc.23575.

PMID:
18498129
[PubMed - indexed for MEDLINE]
13.

64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E(E{E[c(RGDyK)]2}2)2 peptide.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Aug 16 [updated 2008 Feb 21].

14.

Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.

Dijkgraaf I, Kruijtzer JA, Frielink C, Soede AC, Hilbers HW, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC.

Nucl Med Biol. 2006 Nov;33(8):953-61.

PMID:
17127167
[PubMed - indexed for MEDLINE]
15.

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.

Liu Z, Niu G, Wang F, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1483-94. doi: 10.1007/s00259-009-1123-z. Epub 2009 Apr 10.

PMID:
19360404
[PubMed - indexed for MEDLINE]
16.

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Liu Z, Yan Y, Liu S, Wang F, Chen X.

Bioconjug Chem. 2009 May 20;20(5):1016-25. doi: 10.1021/bc9000245.

PMID:
20540537
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.

Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS.

Bioconjug Chem. 2004 Jan-Feb;15(1):41-9.

PMID:
14733582
[PubMed - indexed for MEDLINE]
18.

Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.

Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS.

Bioconjug Chem. 2010 Aug 18;21(8):1417-24. doi: 10.1021/bc900537f.

PMID:
20666401
[PubMed - indexed for MEDLINE]
19.

64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDyK)]2}2.

The MICAD Research Team.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Aug 10 [updated 2007 Aug 29].

20.

Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.

Jiang L, Kimura RH, Miao Z, Silverman AP, Ren G, Liu H, Li P, Gambhir SS, Cochran JR, Cheng Z.

J Nucl Med. 2010 Feb;51(2):251-8. doi: 10.2967/jnumed.109.069831.

PMID:
20124048
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk